4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000899243-22-001618
Director bought 645,000 shares at an average $1.00 ($642,931)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC Director | 2022-01-07 | Purchase | +137,900 | $1.04 | $142,975 | 45,137,900 | I: show line 1 in the form |
| ARMISTICE CAPITAL, LLC Director | 2022-01-10 | Purchase | +491,097 | $0.99 | $484,615 | 45,628,997 | I: show line 2 in the form |
| ARMISTICE CAPITAL, LLC Director | 2022-01-11 | Purchase | +16,003 | $0.96 | $15,342 | 45,645,000 | I: show line 3 in the form |
| Open-market purchases · 645,000 sh · avg $1.00 · $642,931 | |||||||
Loading xslF345X03/doc4.xml…